Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition
Mary J. Savage(Merck & Co., Inc., Rahway, NJ, USA (United States)), Richard W. Scott(Fox Chase Cancer Center)
Cited by 289
Related Papers
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2017|1.3k
Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer
|Journal of Clinical Oncology|2020|292
CNS Amyloid- , Soluble APP- and - Kinetics during BACE Inhibition
|Journal of Neuroscience|2014|40